TSMHT
AVNS

Thurston Springer Miller Herd & Titak’s Avanos Medical AVNS Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-41
Closed -$501 – 594
2025
Q2 		$501 Hold
41
– – ﹤0.01% 1552
2025
Q1 		$587 Hold
41
– – ﹤0.01% 1569
2024
Q4 		$652 Hold
41
– – ﹤0.01% 1244
2024
Q3 		$985 Hold
41
– – ﹤0.01% 1414
2024
Q2 		$816 Hold
41
– – ﹤0.01% 1414
2024
Q1 		$816 Buy
+41
New +$793 ﹤0.01% 155

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's AVNS Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 41 shares — an estimated $501 sold.

Thurston Springer Miller Herd & Titak first reported a position in AVNS in Q1 2024 and held it in 6 quarters. The position peaked at $985 in Q3 2024. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • Thurston Springer Miller Herd & Titak reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 41 Avanos Medical shares in Q3 2025, an estimated $501.
  • Thurston Springer Miller Herd & Titak first reported a position in Avanos Medical in Q1 2024 and held it in 6 quarters.
  • Thurston Springer Miller Herd & Titak's Avanos Medical position peaked at $985 in Q3 2024.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.